Rifaximin Overview Categories 17 Gastrointestinal drugs17.7 Drugs used in diarrhea17.7.2 Antidiarrheals Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Rifaximin Manufacturers of Rifaximin Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Rifaximin's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 200 mg200 (200)8 hourlyoralIt can be taken with or without food.550 mg550 (550)12 hourlyoralThis is indicated for reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Rifaximin is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Rifaximin is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Rifaximin Back to top Manufacturers of Rifaximin in Pakistan Brookes Ferozson Getz S.J.& G Sami Back to top Previous Drug Generic - Next Drug Generic
Rifaximin Overview Categories 17 Gastrointestinal drugs17.7 Drugs used in diarrhea17.7.2 Antidiarrheals Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Rifaximin Manufacturers of Rifaximin Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Rifaximin's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 200 mg200 (200)8 hourlyoralIt can be taken with or without food.550 mg550 (550)12 hourlyoralThis is indicated for reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Rifaximin is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Rifaximin is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Rifaximin Back to top Manufacturers of Rifaximin in Pakistan Brookes Ferozson Getz S.J.& G Sami Back to top Previous Drug Generic - Next Drug Generic